Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary SyndromeMarc A. Pfeffer, Jean‐Claude Tardif, Hertzel C. Gerstein et al.|New England Journal of Medicine|2015Cited by 2.3k
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes MellitusAbhinav Sharma, Christopher B. Granger, Neha J. Pagidipati et al.|Circulation|2020Cited by 108